CompletedPhase 2NCT01863914

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Studying Neonatal diabetes mellitus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cheng-Kung University Hospital
Principal Investigator
Jun-Neng Roan, MD, PhD
National Cheng-Kung University Hospital
Intervention
Rosuvastatin(drug)
Enrollment
60 enrolled
Eligibility
18-65 years · All sexes
Timeline
2012 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01863914 on ClinicalTrials.gov

Other trials for Neonatal diabetes mellitus

Additional recruiting or active studies for the same condition.

See all trials for Neonatal diabetes mellitus →

← Back to all trials